Home » Topics » BioWorld Science

BioWorld Science
RSS

Nektar Therapeutics initiates phase Ib trial of NKTR-358 in patients with SLE

May 9, 2018

Novartis describes novel IKACh channel blockers

May 9, 2018

Novel serine palmitoyltransferase inhibitors identified at Takeda

May 9, 2018

Durable antidepressive effect seen with ALKS-5461 in phase III trial

May 9, 2018

Dare Bioscience enters agreement with Pear Tree Pharmaceuticals to secure rights to PT-101

May 9, 2018

Valeant Pharmaceuticals International to change name to Bausch Health Companies

May 8, 2018

FDA grants fast track designation to Debio-1347

May 8, 2018

Carna collaborates with Evotec to accelerate development of CB-1763

May 8, 2018

Polaris Pharmaceuticals creates new ADI-TRAIL fusion protein with antitumor activity

May 8, 2018

INTEREST study of Traumakine in ARDS does not meet primary efficacy composite endpoint

May 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...